News

Opening Ceremony of Mycenax's New Automated Fill-Finish Line

MYCENAX and CHITOSE Join Forces to Forge a New Era of Cell Line Development

Taiwan’s Regenerative Medicine Acts passed, MYCENAX CDMO Services Are Ready!

Merck Signs MoU with Mycenax Biotech to Drive Innovation in Bioprocessing Technology

Mycenax Biotech has signed an MOU with StemCyte to strengthen its one-stop service chain for allogeneic cell therapy

Construction Commencement of Mycenax Biotech's Cell Therapy Pilot Plant

Mycenax signs MoU with KriSan Biotech: Building ADC Industry Value Chain

JCR Pharmaceuticals invests in Mycenax Biotech, becomes largest shareholder

Mycenax re-elected Dr. Allen Y. Chao as independent director

Grand Opening Ceremony of Mycenax’s New GMP Manufacturing Plant, Zhunan Science Park